权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

UAB-NDRI-SUBSTANCE ABUSE ICOHRTA IN UKRAINE

乌克兰 UAB-NDRI-药物滥用 ICOHRTA

基本信息

批准号：
6897451
负责人：
NALINI SATHIAKUMAR
金额：
$ 27.39万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2001
资助国家：
美国
起止时间：
2001-09-27 至 2007-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/6897451
关键词：
AIDS Commonwealth of Independent States Europe HIV infections disease /disorder prevention /control epidemiology international cooperation intravenous drug abuse sexually transmitted diseases substance abuse related disorder tuberculosis

项目摘要

DESCRIPTION (provided by applicant): Our proposal is a collaborative effort between the University of Alabama at Birmingham (UAB), the National Development and Research Institute, Inc. (NDRI) and the Pirogov Medical University in Vinnitsa, Ukraine. The purpose of this initiative is to strengthen and sustain, through collaborative training and research, the ability of Ukrainian scientists, physicians, and public health practitioners to contribute to clinical, operational and health services research focused on substance abuse treatment and prevention, and prevention and control of the related epidemics of human immunodeficiency virus (HIV) infection with a particular focus on injection drug use (IDU) and the attendant epidemics of human immunodeficiency virus (HIV), sexually transmitted diseases (STD), and tuberculosis (TB). To develop the Pirogov Medical University into a regional center for training and research excellence, we have designed a program of training that will prepare Pirogov scholars and students to address all the key issues pertaining to IDU-related clinical, operational, and health services research in Ukraine as well as to participate effectively in research that addresses global problems in HIV/STD/TB prevention and control emphasizing communities with substantial IDU populations. Our training program is multidisciplinary and includes clinical research, international health, epidemiology, health behavior, biostatistics, health policy, and key principles in both intervention and treatment research. Our research goals are to better understand the IDU epidemic in Ukraine in order to guide treatment and control strategies, as well as to upgrade evidence-based approaches to the closely related epidemics of HIV infection, STDs, and TB in the services of their control and prevention. The selection of the Pirogov Medical University as the key training center was done with four key factors in mind: (1) Pirogov is one of the premier medical schools in all of eastern Europe; (2) Fully one-quarter of Pirogov?s medical students come from outside the Ukraine, making it an international training site; (3) Pirogov and UAB have been collaborating on research and training for over two years and have a written, substantive agreement to collaborate, co-signed by the President of Pirogov Medical University and the Provost of UAB in Birmingham in March 2000; and (4) UAB and NDRI have complementary expertise and have a close working relationship.

描述（由申请人提供）：我们的建议是一个合作的努力在伯明翰的亚拉巴马大学（UAB），国家发展研究所，Inc。（NDRI）和Pirogov医科大学，乌克兰文尼察。这一倡议的目的是加强和维持，通过合作培训和研究，乌克兰的能力，科学家、医生和公共卫生从业人员，以药物滥用为重点的临床、业务和卫生服务研究治疗和预防，以及相关流行病的预防和控制艾滋病毒（艾滋病毒）感染的影响，特别侧重于注射吸毒和随之而来的人体免疫缺陷病毒（HIV）、性传播疾病（STD）和结核病（TB）。到将Pirogov医科大学发展成为区域培训中心，研究卓越，我们设计了一个培训计划，将准备 Pirogov学者和学生解决所有有关的关键问题，乌克兰与注射吸毒相关的临床、操作和卫生服务研究，并有效参与解决全球问题的研究在艾滋病毒/性病/结核病预防和控制方面， IDU人群。我们的培训计划是多学科的，包括临床研究，国际卫生，流行病学，健康行为，生物统计学、卫生政策以及干预和治疗研究。我们的研究目标是更好地了解IDU 为了指导治疗和控制战略，以改进循证方法，应对与艾滋病毒密切相关的流行病，传染病、性病和结核病的控制和预防服务。的选择Pirogov医科大学作为重点培训中心考虑到四个关键因素：（1）Pirogov是最重要的医疗机构之一学校在所有东欧;（2）充分四分之一的Pirogov？的医疗学生来自乌克兰境外，使其成为国际培训（3）Pirogov和UAB一直在合作研究和培训，超过两年，并有一个书面的，实质性的合作协议，由Pirogov医科大学校长和UAB教务长共同签署 2000年3月在伯明翰举行;以及（4）UAB和NDRI具有互补的专业知识并保持密切的工作关系。